Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
ALTEOGEN will issue and list 146,140 additional common shares following the exercise of stock options by executives and employees. The listing date is set for May 28, 2025.
📊 [Key Disclosure Details & Major Figures Summary]
- Company Name: ALTEOGEN Inc. (Ticker: A196170)
- Type & Number of Additional Shares: Common Stock 146,140 shares
- Par Value per Share: KRW 500
- Total Issued Shares After Listing: Common Stock 53,464,968 shares (Dividend record date: January 01, 2025)
- Listing Date: May 28, 2025
- Issuance Breakdown (Stock Option Exercises):
- 107th Tranche (Issued May 16, 2025): 60,000 Common shares / Exercise price KRW 8,917
- 108th Tranche (Issued May 16, 2025): 20,000 Common shares / Exercise price KRW 21,111
- 109th Tranche (Issued May 16, 2025): 4,000 Common shares / Exercise price KRW 23,833
- 110th Tranche (Issued May 16, 2025): 40,000 Common shares / Exercise price KRW 63,889
- 111th Tranche (Issued May 16, 2025): 7,200 Common shares / Exercise price KRW 72,875
- 112th Tranche (Issued May 16, 2025): 7,200 Common shares / Exercise price KRW 62,858
- 113th Tranche (Issued May 16, 2025): 7,740 Common shares / Exercise price KRW 47,417
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Additional Share Listing Schedule and Total Listed Share Count
This disclosure formally reports the additional listing of new common shares resulting from stock option exercises. Confirming that the 146,140 new common shares are listed on the scheduled date (May 28, 2025) and accurately reflected in the total listed share count (53,464,968 shares) is essential because it allows investors to verify the completion of the new share listing process. Detailed updates can be cross-checked in subsequent periodic reports (Quarterly, Half-Yearly, and Annual Reports) and related disclosure filings.
📢 Disclaimer & Source Notice
Source: This content has been structured and newly created based on official filing data from the Financial Supervisory Service (DART).
Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
